Journals / Turkish Journal of Veterinary and Animal Sciences / 2013 / Cilt: 37 - Sayı: 5

Enhancement of immune response for Newcastle disease vaccine using a combined adjuvant solution of Astragalus polysaccharides, levamisole, and selenoprotein

Pages
516–522
Publication Date
2013-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that both the humoral and cellular immune responses were significantly enhanced compared to the negative control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Newcastle disease vaccine strain I (ND I vaccine) was reconstituted using a 3-component combined adjuvant solution containing Astragalus polysaccharide (APS), levamisole (LMS), and selenoprotein (Se).
📊
Key Findings & Data:A total of 200 Hy-Line brown chickens, 60 days of age, were randomly assigned into 10 groups.
💡
Conclusion & Impact:The results showed that both the humoral and cellular immune responses were significantly enhanced compared to the negative control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Astragalus polysaccharides · selenium · levamisole

Abstract

The Newcastle disease vaccine strain I (ND I vaccine) was reconstituted using a 3-component combined adjuvant solution containing Astragalus polysaccharide (APS), levamisole (LMS), and selenoprotein (Se). A total of 200 Hy-Line brown chickens, 60 days of age, were randomly assigned into 10 groups. The first group was a negative control and was immunized using the phosphate buffered saline-reconstituted vaccine. The other 9 groups were immunized using the vaccine reconstituted with the combined adjuvant solution. The serum and blood samples were collected on days 7, 14, 21, 27, 35, and 42 after the vaccinations and were analyzed for IgG, IL-2, and IL-6 as well as T cell proliferation. The results showed that both the humoral and cellular immune responses were significantly enhanced compared to the negative control group. The IgG level was higher and prolonged. The IL-2 and IL-6 expressions as well as the T cell proliferation were enhanced in the experimental groups. The best combination was APS 9 mg/mL + Se 0.01 mg/mL + LMS 30 mg/mL. Our data confirmed the previous studies on immune enhancement of APS, Se, or LMS alone, but also indicated the synergy of APS + Se + LMS on the vaccine immunization.

Özet

The Newcastle disease vaccine strain I (ND I vaccine) was reconstituted using a 3-component combined adjuvant solution containing Astragalus polysaccharide (APS), levamisole (LMS), and selenoprotein (Se). A total of 200 Hy-Line brown chickens, 60 days of age, were randomly assigned into 10 groups. The first group was a negative control and was immunized using the phosphate buffered saline-reconstituted vaccine. The other 9 groups were immunized using the vaccine reconstituted with the combined adjuvant solution. The serum and blood samples were collected on days 7, 14, 21, 27, 35, and 42 after the vaccinations and were analyzed for IgG, IL-2, and IL-6 as well as T cell proliferation. The results showed that both the humoral and cellular immune responses were significantly enhanced compared to the negative control group. The IgG level was higher and prolonged. The IL-2 and IL-6 expressions as well as the T cell proliferation were enhanced in the experimental groups. The best combination was APS 9 mg/mL + Se 0.01 mg/mL + LMS 30 mg/mL. Our data confirmed the previous studies on immune enhancement of APS, Se, or LMS alone, but also indicated the synergy of APS + Se + LMS on the vaccine immunization.

🔖

Cite This Article

SUN, Y., XIE, X., HE, J., JIANG, J., NIU, R., BAI, Y., LI, H. (2013). Enhancement of immune response for Newcastle disease vaccine using a combined adjuvant solution of Astragalus polysaccharides, levamisole, and selenoprotein. Turkish Journal of Veterinary and Animal Sciences, Cilt: 37 - Sayı: 5, 516–522. https://ajindex.com/articles/121882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Liang R, Cao DJ, Li JQ, Chen J, Guo X, Zhuang FF, Duan MX. Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII. Vet Microbiol 2002; 87: 193–203.
  2. Bogoyavlenskiy A, Berezin V, Prilipov A, Usachev E, Lyapina O, Korotetskiy I, Zaitceva I, Asanova S, Kydyrmanov A, Daulbaeva K et al. Newcastle disease outbreaks in Kazakhstan and Kyrgyzstan during 1998, 2000, 2001, 2003, 2004, and 2005 were caused by viruses of the genotypes VIIb and VIId. Virus Genes 2009; 39: 94–101.
  3. Fan Y, Hu Y, Wang D, Guo Z, Zhao X, Guo L, Zhao B, Zhang J, Wang Y, Nguyen TL. Epimedium polysaccharide and propolis flavone can synergistically stimulate lymphocyte proliferation in vitro and enhance the immune responses to ND vaccine in chickens. Int J Bio Macromol 2010; 47: 87–92.
  4. Bowersock TL, Martin S. Vaccine delivery to animals. Adv Drug Deliv Rev 1999; 38: 167–194.
  5. Guo Z, Hu Y, Wang D, Ma X, Zhao X, Zhao B, Wang J, Liu P. Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine. Vaccine 2009; 27: 660–665.
  6. Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, Wang B. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004; 22: 2925–2935.
  7. Kang Y, Jin H, Zheng G, Xie Q, Yin J, Yu Y, Xiao C, Zhang X, Chen A, Wang B. The adjuvant effect of levamisole on killed viral vaccines. Vaccine 2005; 23: 5543–5550.
  8. Goldson AJ, Fairweather-Tait SJ, Armah CN, Bao Y, Broadley MR, Dainty JR, Furniss C, Hart DJ, Teucher B, Hurst R. Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial. PLoS One 2011; 6: e14771. Vecchi S, Bufali S, Skibinski DA, O’Hagan DT, Singh M. Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations. J Pharm Sci 2012; 101: 17–20. Renoux G. The general immunopharmacology of levamisole. Drugs 1980; 19: 89–99.
  9. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352–358.
  10. Monz BU, Konig HH, Leidl R, Staib L, Link KH. Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany. Pharmacoeconomics 2003; 21: 709–719.
  11. Tsavaris N, Gennatas K, Kosmas C, Skopelitis HM, Gouveris P, Dimitrakopoulos A, Zacharakis M, Kouraklis G, Vasiliou J, Felekouras E et al